article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. Competition starts to heat up. Classic treatment options.

article thumbnail

$2 billion mRNA-based oncology therapy market anticipated by 2029

European Pharmaceutical Review

OTX-2002 from Omega Therapeutics is an mRNA therapy anticipated to generate $658 million in global sales, representing 33.2 Omega Therapeutics’s share suggests increasing competition and diversification in this innovative field,” concluded Podder. percent of the total mRNA therapy market by 2029.

Marketing 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4

Medicine 116
article thumbnail

Indivior must go to court over addiction drug monopoly claim

pharmaphorum

Indivior has failed in its bid to prevent a lawsuit claiming that it illegally blocked competition to opioid addiction drug Suboxone from coming to court in the US. Indivior made an application for a judgment in its favour without coming to trial, but that has been denied by Judge Mitchell Goldberg in a Philadelphia court. .”

article thumbnail

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

article thumbnail

Using alkali-metal cation recognition of ?-cyclodextrin to detect lithium ions by MALDI-TOF

European Pharmaceutical Review

1,7 It may depend on the competition between 6 Li and 7 Li, present at much higher concentration, to be ionised. Enzymatic production of cyclodextrins, Applied Microbiology and Biotechnology , 2002, 59, 609-617. Lithium, due to its smaller radius and high polarising strength, can replace Na + and K + in α-CD. percent and 7.5=

article thumbnail

12 Brilliant Healthcare Marketing Campaign Initiatives

Medico Reach

To address the shortage of nurses in the US , Johnson & Johnson started the Nurses’ Future initiative in 2002. The Anne Arundel’s Medical Center hosted a competition that required participants to submit a selfie with a natural or fake mustache. ‘Preparing Nurses for The Future’ by Johnson & Johnson.